The impact of HER3 dynamics on the efficacy of HER3-DXd, a novel HER3 directed antibody- drug conjugate

被引：2
|
作者：
Komatsu, Nagiho
Sato, Saori
Muramatsu, Sumie
Nakamura, Ryuichi
Koyama, Kumiko
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3996
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3996
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Updated efficacy and safety of patritumab deruxtecan (HER3-DXd; U3-1402), a HER3 directed antibody drug conjugate, in EGFRm NSCLC
    Hayashi, Hidetoshi
    Yu, Helena A.
    Baik, Christina
    Gold, Kathryn
    Johnson, Melissa L.
    Koczywas, Marianna
    Murakami, Haruyasu
    Nishio, Makoto
    Steuer, Conor
    Su, Wu-Chou
    Yang, James C. H.
    Karam, Samer
    Qui, Zhenhao
    Qiu, Yang
    Chen, Shuquan
    Yu, Channing
    Janne, Pasi A.
    ANNALS OF ONCOLOGY, 2021, 32 : S318 - S318
  • [2] EGFR inhibitor upregulates HER3 expression and enhances the efficacy of HER3 targeting patritumab deruxtecan (HER3-DXd)
    Yonesaka, Kimio
    Tanizaki, Junko
    Maenishi, Osamu
    Sakai, Kazuko
    Goto, Hiroki
    Kobayashi, Maki
    Yoshimoto, Ryoto
    Otsuka, Eri
    Okida, Hiroaki
    Funabashi, Masanori
    Hashimoto, Yuuri
    Hirotani, Kenji
    Kagari, Takashi
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    CANCER SCIENCE, 2022, 113 : 896 - 896
  • [3] Efficacy and Safety of the Novel HER3 Directed Antibody Drug Conjugate Patritumab Deruxtecan (HER3-DXd; U3-1402) in EGFR-mutated NSCLC
    Yu, H.
    Baik, C.
    Gold, K.
    Hayashi, H.
    Johnson, M.
    Koczywas, M.
    Murakami, H.
    Nishio, M.
    Steuer, C.
    Su, W.
    Yang, J. C.
    Karam, S.
    Qi, Z.
    Qiu, Y.
    Chen, S.
    Yu, C.
    Janne, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S107 - S107
  • [4] Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression
    Koyama, Kumiko
    Ishikawa, Hirokazu
    Abe, Manabu
    Shiose, Yoshinobu
    Ueno, Suguru
    Qiu, Yang
    Nakamaru, Kenji
    Murakami, Masato
    PLOS ONE, 2022, 17 (05):
  • [5] Antitumor effect of HER3-DXd, an antibody-drug conjugate targeting HER3, in gastric cancer cell lines
    Hwang, Hae Min
    Kim, So Hyeon
    Ham, Sujin
    Lee, Minyoung
    Noh, Youlim
    Kim, Yu-Jin
    Lee, Changyun
    Kim, Jinyoung
    Lee, Dae-Won
    Lee, Kyung-Hun
    Im, Seock-Ah
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [6] EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd
    Haikala, Heidi M.
    Lopez, Timothy
    Kohler, Jens
    Eser, Pinar O.
    Xu, Man
    Zeng, Qing
    Teceno, Tyler J.
    Ngo, Kenneth
    Zhao, Yutong
    Ivanova, Elena, V
    Bertram, Arrien A.
    Leeper, Brittaney A.
    Chambers, Emily S.
    Adeni, Anika E.
    Taus, Luke J.
    Kuraguchi, Mari
    Kirschmeier, Paul T.
    Yu, Channing
    Shiose, Yoshinobu
    Kamai, Yasuki
    Qiu, Yang
    Paweletz, Cloud P.
    Gokhale, Prafulla C.
    Janne, Pasi A.
    CANCER RESEARCH, 2022, 82 (01) : 130 - 141
  • [7] Therapeutic potential of a HER3 antibody-drug conjugate for the treatment of HER3-expressing cancers
    O'Hare, Thomas
    Cleveland, Jaclyn
    Jansen, Valerie M.
    Dornan, David
    CANCER RESEARCH, 2024, 84 (06)
  • [8] A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
    Zong, Hui-fang
    Li, Xi
    Han, Lei
    Wang, Lei
    Liu, Jun-jun
    Yue, Ya-li
    Chen, Jie
    Ke, Yong
    Jiang, Hua
    Xie, Yue-qing
    Zhang, Bao-hong
    Zhu, Jian-wei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (08) : 1727 - 1739
  • [9] EGFR inhibitor upregulates HER3 expression and enhances the efficacy of anti-HER3 antibody drug conjugate U3-1402
    Yonesaka, Kimio
    Tanizaki, Junko
    Maenishi, Osamu
    Kawakami, Hisato
    Tanaka, Kaoru
    Hayashi, Hidetoshi
    Takeda, Masayuki
    Sakai, Kazuko
    Kobayashi, Maki
    Yoshimoto, Ryoto
    Goto, Hiroki
    Funabashi, Masanori
    Hashimoto, Yuuri
    Hirotani, Kenji
    Kagari, Takashi
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2021, 32 : S296 - S296
  • [10] Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer
    Yun, Chen
    Gang, Li
    Gu Rongmin
    Xu, Wen
    Ming Xuezhi
    Chen Huanqiu
    MOLECULAR CARCINOGENESIS, 2015, 54 (12) : 1700 - 1709
12345